Sun Pharmaceutical Industries Inc. and its subsidiary Taro Pharmaceuticals USA Inc. gained final approval of a $200 million antitrust deal to settle claims they conspired with other drugmakers to ...

SHANGHAI, Jan 27 (Reuters) - China's medicine regulator has ordered a halt to the import, sale and usage of a drug used to ...

Sun Pharma has downplayed a rumour that it is in talks to acquire women's health specialist Organon, after a report suggested ...

Sun Pharma has addressed speculation regarding a potential $10 billion acquisition of US firm Organon. The Indian drugmaker ...

Discover the Sun Pharma Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

For Sun Pharma, the December-quarter print is expected to reaffirm its role as a defensive compounder within the large-cap pharma space ...

Sana Shaikh has taken over as the Head of Marketing at Sun Pharma, marking a significant move in her professional journey.

India-based Sun Pharmaceutical Industries Ltd is reportedly evaluating a potential acquisition of Organon & Co (NYSE:OGN), a ...

Regulatory authorities in China have cracked down on Sun Pharma’s rivastigmine-based Alzheimer’s disease treatment, halting ...

Media reports this week suggested that Sun Pharma is in discussions with lenders to arrange financing for the acquisition and has submitted non-binding bids, which could value Organon at over $10 ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...